• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Small cell adhesion glycoprotein (SMAGP), Truncated

ACP18566

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP18566 Target NameSMAGP
Target SynonymshSMAGP; Smagp; SMAGP_HUMAN; Small cell adhesion glycoprotein; small cell transmembrane and glycosylated protein; Small transmembrane and glycosylated proteinFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ0VAQ4
Background Information
  • Uniprot Id

    Q0VAQ4

  • Target Species

    Human

  • Target Name

    SMAGP

  • Target Full Name

    Small cell adhesion glycoprotein

  • Target Function

    May play a role in epithelial cell-cell contacts. May play a role in tumor invasiveness and metastasis formation.

  • Target Subcellular Location

    Cell membrane; Single-pass type III membrane protein. Cytoplasmic vesicle membrane; Single-pass type III membrane protein.

  • Target Protein Families

    SMAGP family

  • Target Tissue Specificity

    Detected in breast, endometrium, colon and biliary tract. Detected in polarized epithelial structures characterized by cell-cell adhesion (at protein level).

  • Target Synonyms

    hSMAGP; Smagp; SMAGP_HUMAN; Small cell adhesion glycoprotein; small cell transmembrane and glycosylated protein; Small transmembrane and glycosylated protein

Inquire Recombinant Human Small cell adhesion glycoprotein (SMAGP), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification